Vitamin K2: The Complete Guide

Vitamin K2 (menaquinone) is a fat-soluble vitamin distinct from K1 (phylloquinone, found in leafy greens). K2 exists in several forms (MK-4 through MK-13), with MK-4 and MK-7 being the most supplemented. K2's primary role is activating vitamin K-dependent proteins that manage calcium metabolism.

The 'calcium paradox' explains why K2 matters: many people have sufficient calcium intake but poor calcium distribution, calcium ends up in arteries instead of bones. K2 activates matrix Gla protein (MGP) which inhibits arterial calcification, and osteocalcin which directs calcium into bone matrix.

Cardiovascular: The Rotterdam Study (2004) found high K2 intake associated with reduced arterial calcification and lower cardiovascular mortality. MK-7 supplementation (180mcg/day for 3 years) reduced arterial stiffness in postmenopausal women.

Bone health: K2 activates osteocalcin, enabling it to bind calcium in bone. Japanese trials using MK-4 (45mg/day) showed reduced fracture rates. MK-7 at lower doses (100–200mcg) shows similar bone density benefits in 1–3 year trials.

D3 synergy: Vitamin D3 increases intestinal calcium absorption and osteocalcin production, but osteocalcin requires K2-dependent carboxylation to function. Supplementing D3 without K2 may increase uncarboxylated (inactive) osteocalcin and potentially accelerate arterial calcification in deficient individuals.

Peter Attia and Rhonda Patrick both emphasize D3+K2 co-supplementation as standard practice for anyone taking vitamin D above food-level doses.

D3+K2 combo: 2000–5000 IU vitamin D3 + 100–200mcg MK-7 daily, taken with a fat-containing meal for absorption. Combined D3+K2 products (Thorne, Life Extension) simplify dosing.

MK-7 vs MK-4: MK-7 (100–200mcg/day) is the modern standard, longer half-life (72 hours vs 4–6 hours for MK-4), once-daily dosing. MK-4 (45mg/day, 3× daily) has more Japanese clinical trial data but requires much higher doses.

Testing: No standard K2 blood test in routine panels. Measure D3 levels (target 40–60 ng/mL) and ensure K2 co-supplementation. Undercarboxylated osteocalcin (ucOC) is a research marker for K2 status.

Food sources: Natto (fermented soybeans) is the richest MK-7 source (~1000mcg/100g). Hard cheeses (Gouda, Brie) provide MK-7 and MK-9. Most Western diets provide insufficient K2 without supplementation.

K2 is not acutely felt. Benefits are structural and long-term: bone density maintenance, arterial health, and proper calcium metabolism.

Month 1–3: No subjective change. D3 level improvements may be measurable on blood panels.

Year 1+: Bone density and arterial calcification changes require DEXA and calcium scoring to assess. K2 is preventive, not corrective for existing calcification.

Warfarin interaction: K2 opposes warfarin (a vitamin K antagonist). Patients on blood thinners must NOT supplement K2 without medical supervision.

Pregnancy: K2 is generally considered safe at supplemental doses, but MK-7 long-term data in pregnancy is limited. Food sources (cheese) are safe.

No toxicity: No established upper limit for K2. Unlike D3, excess K2 has no known toxic threshold in human studies.

r/Supplements consensus: if you take D3, take K2. 'D3 without K2 is incomplete' is one of the most repeated phrases. Thorne D/K2 Liquid and Life Extension Advanced K2 are top recommendations.

Peter Attia discusses K2 on podcast episodes about cardiovascular prevention. Rhonda Patrick emphasizes natto as a food source but acknowledges most people need supplementation. Combined D3+K2 products dominate the market for good reason.